MAP2K4 Protein, Human (P. pastoris, His-GST)

The MAP2K4 protein is a dual-specificity kinase involved in the MAP kinase pathway. MAP2K4 Protein, Human (P. pastoris, His-GST) is the recombinant human-derived MAP2K4 protein, expressed by P. pastoris , with N-6*His, N-GST labeled tag. The total length of MAP2K4 Protein, Human (P. pastoris, His-GST) is 398 a.a., with molecular weight of 71.5 kDa.

MAP2K4, a dual specificity protein kinase, serves as a pivotal component in the MAP kinase signal transduction pathway, particularly in the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling cascade. Teaming up with MAP2K7/MKK7, MAP2K4 stands out as one of the few known kinases capable of directly activating stress-activated protein kinases, including MAPK8/JNK1, MAPK9/JNK2, and MAPK10/JNK3, through phosphorylation of the Thr-Pro-Tyr motif. While both MAP2K4/MKK4 and MAP2K7/MKK7 contribute to JNK activation, their preferences for phosphorylation sites within this motif differ. MAP2K4 favors phosphorylation of the Tyr residue, whereas MAP2K7/MKK7 prefers the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 appears crucial for JNK activation, especially in response to pro-inflammatory cytokines, while other stimuli engage both MAP2K4/MKK4 and MAP2K7/MKK7 in a synergistic phosphorylation of JNKs. Notably, MAP2K4 plays an essential role in maintaining peripheral lymphoid homeostasis and participates in the mitochondrial death signaling pathway, leading to apoptosis. While MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 goes a step further by additionally activating the p38 MAPKs MAPK11, MAPK12, MAPK13, and MAPK14.

Human

P. pastoris

N-6*His;N-GST

P45985 (A2-D399)

6416  [NCBI]

AAPSPSGGGGSGGGSGSGTPGPVGSPAPGHPAVSSMQGKRKALKLNFANPPFKSTARFTLNPNPTGVQNPHIERLRTHSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVD

71.5 kDa

Greater than 90% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.